Tirzepatide reduced sleep apnea with and without CPAP use. We review sleep apnea, the new studies, drug side effects, and cost issues.
Eli Lilly announced on April 17, 2024, that tirzepatide achieved a mean apnea-hypopnea index reduction of up to 63%, meeting all primary and key secondary endpoints in two phase 3 clinical trials.
Let's review what sleep apnea is, the new studies, the potential side effects of the drug, and cost issues.
A new blood test is approved for colon cancer screening. What are its pros and cons, and how does it compare to the GRAIL Galleri test?
Primary care physicians don't usually check lipoprotein (a), but we should. Elevated levels (≥50 mg/dL) are a genetic condition (LPA gene) that affects about 20% of people and significantly increases atherosclerotic coronary vascular disease and aortic valve stenosis.
The June ACIP meeting brought new rules about which older people should get RSV vaccine. And a new mRNA RSV vaccine from Moderna that had no GBS signal.
The new Endocrine Society Guideline says don't test vitamin D levels in healthy people, and healthy adults between 18 and 75 years old mostly don't need vitamin D supplements.
Healthy Insight, LLC © . All rights reserved.